Clinical Trial Update: Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy [Phase 1]

View source ↗

Summary

The Phase 1 trial evaluating entolimod in combination with cisplatin and radiation for stage III-IV head and neck squamous cell carcinoma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Entolimod (entolimod)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Mucositis, Recurrent Squamous Cell Carcinoma of the Hypopharynx | Phase 1 | Status: WITHDRAWN